Soo-Ryum (Stew) Yang MD

In a Review now published online, Guilherme Harada, Soo-Ryum Yang, @emilianoCocco2 and @alexdrilon discuss some molecular subtypes of #lungcancer that, despite occurring in <5% of patients with this cancer type, affect a considerable number of individuals nature.com/articles/s4157…

🔍 Accurate HER2 testing matters. 🧬 Explore targeted therapies for HER2-mutated NSCLC, 🩺 tailor treatment strategies to individual patients, and 🤝 engage multidisciplinary teams and patients in shared decision-making across the care continuum. ➡️ bit.ly/3Zqwrfn

One more week until the FIRST @cure_today Young-Onset Lung Cancer Summit! 🗓️ Saturday, April 26 ⏰ 10 AM CT Excited to welcome these two amazing multidisciplinary colleagues of mine!! Register here: globalmeet.webcasts.com/starthere.jsp?…

🧬 Explore evolving treatments for NSCLC with HER2 mutations! 🩺 Gain confidence in biomarker interpretation, personalized care plans, and tackling barriers to care. 📍 Learn more: ms.spr.ly/6011UrKkP @lungoncdoc #NSCLC #OncologyInnovation

Lots of excitement with the @IASLC educational Amazing Case Race! Be sure to vote for your favorite one! #WCLC24 @sooryumyang @ChristianRolfo @RManochakian form.jotform.com/242185721762155

🧬 Dive into the clinical implications of EGFR mutations in NSCLC. Learn to evaluate mutational status and use it to guide therapy plans. Enhance your diagnostic and treatment decisions through effective communication! 🎯 Join @sooryumyang & other experts: ms.spr.ly/6013Y2a0h